Related Experiment Video
Updated: May 5, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Future directions in the prevention of prostate cancer
Ian M Thompson1, April B Cabang1, Michael J Wargovich1
1Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, Mail Code 8026, 7979 Wurzbach, Suite 627, Zeller Building, San Antonio, TX 78229, USA.
Abstract:
The high global incidence of prostate cancer has led to a focus on chemoprevention strategies to reduce the public health impact of the disease. Early studies indicating that selenium and vitamin E might protect against prostate cancer encouraged large-scale studies that produced mixed clinical results. Next-generation prostate cancer prevention trials validated the impact of 5α-reductase inhibitors in hormone-responsive prostate cancer, and these results were confirmed in follow-up studies. Other interventions on the horizon, involving both dietary and pharmacological agents, hold some promise but require further investigation to validate their efficacy. In this Review, we discuss the clinical and preclinical evidence for dietary and pharmacological prevention of prostate cancer and give an overview of future opportunities for chemoprevention.
Insights
Prostate cancer chemoprevention strategies are being explored, with mixed results for supplements like selenium and vitamin E, but promising findings for 5α-reductase inhibitors. Future research will investigate new dietary and pharmacological agents.
Area of Science:
- Oncology
- Preventive Medicine
- Pharmacology
Background:
- High global incidence of prostate cancer necessitates effective prevention strategies.
- Early chemoprevention studies with selenium and vitamin E yielded mixed results.
- 5α-reductase inhibitors show promise in hormone-responsive prostate cancer prevention.
Purpose of the Study:
- To review clinical and preclinical evidence for prostate cancer chemoprevention.
- To provide an overview of current and future chemoprevention opportunities.
Main Methods:
- Review of clinical trial data.
- Analysis of preclinical research findings.
- Synthesis of evidence on dietary and pharmacological interventions.
Main Results:
- Selenium and vitamin E showed inconsistent efficacy in large-scale studies.
- 5α-reductase inhibitors demonstrated validated efficacy in hormone-responsive prostate cancer.
- Emerging dietary and pharmacological agents require further investigation.
Conclusions:
- Prostate cancer chemoprevention is an evolving field with ongoing research.
- Validated interventions like 5α-reductase inhibitors offer a path forward.
- Further investigation is crucial for novel chemopreventive agents.
More Related Videos
Related Concept Videos
Preventive Healthcare Services
Cancer Prevention
Some...
Cancer Prevention
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Targeted Cancer Therapies
There are several types of targeted therapies against...

